Results 191 to 200 of about 25,087 (209)

Venetoclax

Reactions Weekly, 2019
  +6 more sources

Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

Signal Transduction and Targeted Therapy, 2022
Qi Zhang, Lina Han, Alessia Lodi
exaly  

Venetoclax

Reactions Weekly, 2017
openaire   +1 more source

Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells

Nature Cancer, 2020
Daniel A Pollyea, Rachel Culp-Hill, Angelo D'Alessandro   +2 more
exaly  

Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia

Nature Cancer, 2021
Claudie Bosc, Marie Sabatier, Guillaume Cognet   +2 more
exaly  

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia

Signal Transduction and Targeted Therapy, 2020
Jeffrey W Taub, Yubin Ge
exaly  

Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia

Nature Cancer, 2020
Haijiao Zhang, Yusuke Nakauchi, Thomas Köhnke   +2 more
exaly  

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

Nature Medicine, 2018
Daniel A Pollyea, Shanshan Pei, Angelo D'Alessandro   +2 more
exaly  

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

New England Journal of Medicine, 2020
Courtney D Dinardo, Brian A Jonas, Vinod Pullarkat   +2 more
exaly  

Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

Cancer Discovery, 2016
Marina Y Konopleva, Daniel A Pollyea, Ahmed Hamed Salem   +2 more
exaly